Introduction: A simple, sensitive stability-indicating reversed-phase high-performance liquid chromatography (RP-HPLC) method for the determination of palbociclib. Palbociclib is an anticancer drug used for the treatment of breast cancer. It is a selective inhibitor of cyclin-dependent kinases. Materials and Methods: Waters Model 2695 alliance HPLC system (PDA Detector) with Inertsil ODS-3V (4.6 mm × 250 mm, 5 µm) was used for the chromatographic separation. Mobile phase consisting of ammonium acetate:acetonitrile (32:68, v/v) was delivered at a flow rate of 1.0 ml/min (detection wavelength 263 nm) on isocratic mode for the chromatographic study. Results and Discussion: Palbociclib obeys Beer Lambert's Law over a concentration range 5-1000 µg/ ml. The limit of detection and limit of quantification are found to be 1.6378 and 4.951 µg/ml. The method was validated as per the ICH guidelines. Forced degradation studies were conducted, and the method was found to be specific. Conclusion: The present RP-HPLC method is simple, precise, and accurate and can be used for the routine analysis of pharmaceutical formulations.
INTRODUCTION

P albociclib [
] is a new drug used for the treatment of breast cancer. US Food and Drug Administration (FDA) has given approval for Palbociclib. [1] FDA has indicated that palbociclib has to be used along with Letrozole which is an aromatase inhibitor. Palbociclib is used in the first-line treatment for postmenopausal women with metastatic breast cancer that is estrogen receptor (ER) -positive and human epidermal growth factor receptor 2 (HER2) -negative. Palbociclib also acts as an inhibitor of cyclin-dependent kinases 4 and 6, which are involved in promoting the growth of cancer cells. [2] Addition of palbociclib to letrozole provides a novel treatment for women diagnosed with metastatic breast cancer. Dange et al. have established a liquid chromatographic method [3] for the simultaneous determination of palbociclib to letrozole and Song et al. developed a reversed-phase high-performance liquid chromatography (RP-HPLC) method for the quantification of palbociclib in capsules. [4] So far, there is not even single stability indicating liquid chromatographic method in the literature and the authors, therefore, have attempted a simple RP-HPLC method for the assay of palbociclib and validated as per the ICH guidelines. [5] 
MATERIALS AND METHODS
Chemicals and Reagents
Palbociclib was procured from Ther Dose Pharma Pvt., Ltd., (India). Palbociclib capsules are available with brand names: IBRANCE ® 125 mg; 100 mg; 75 mg; and Palbace 125 mg. All other chemicals are of AR grade, and all solvents are of HPLC grade. The analysis of palbociclib was performed using Waters 2695 alliance HPLC system with 2996PDA detector.
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Optimized Chromatographic Conditions
Waters Model 2695 alliance HPLC system with Inertsil ODS-3V (4.6 mm × 250 mm, 5 µm) was used for the chromatographic study. Waters 2996 Photodiode array detector was used. Chromatographic method was developed in isocratic mode with ammonium acetate with pH adjusted to 8 using TEA:acetonitrile (ACN) (38:62, v/v) was delivered with a flow rate of 1.0 ml/min and column temperature maintained at 30°C with a runtime of 30 min. The ultraviolet detection was carried out with PDA detector at 263 nm.
Preparation of Stock Solution
25 mg of palbociclib was dissolved in 5 ml of water initially and made up to volume with ACN in a 25 ml volumetric flask and was filtered through a 0.45 µm membrane filter.
Method Validation
The method was validated by evaluating linearity, precision, accuracy, recovery, limit of detection (LOD), limit of quantification (LOQ), system suitability, solution stability, and robustness as per the ICH Guidelines.
Linearity, Precision, Accuracy, and Robustness Studies
Different diluted solutions of 5-1000 µg/ml were prepared from the stock solution and injected into the RP-HPLC system, and peak area of chromatogram was noted. A graph was plotted with a concentration on X-axis and mean peak area on Y-axis. Intraday and interday precision was calculated using three different concentrations on the same day and the 3 consecutive days, respectively. The accuracy of the method was proved by standard addition method, and the recovery values were determined. The robustness indicates its efficiency to remain unaffected with small and deliberate changes in the analytical procedure and provides an assurance of its analysis. The proposed method was checked for robustness by slightly changing the flow rate (± 0.1 mL), mobile phase composition (± 2%), pH (± 0.2 units), and detection wavelength (258 nm and 268 nm).
Assay of Palbociclib in the Laboratory Prepared Formulation
Palbociclib is still under development, and therefore, palbociclib capsules were prepared in our laboratory with the available excipients and then extracted with mobile phase. This solution was filtered and diluted as per the requirement with mobile phase.
Stress Degradation Studies
Forced degradation studies were performed to test the drug to withstand its properties in the applied stress conditions. Palbociclib was exposed to different stress conditions such as acidic, basic, and peroxide conditions (ICH guidelines). [6] Acid degradation was performed by treating palbociclib drug solution with 1 ml of 5N HCl at a temperature of 80°C for 1 h in a thermostat and later the solution was neutralized with sodium hydroxide solution and diluted with mobile phase as per the requirement after filtration through 0.45 µ Similarly, for base degradation, palbociclib solution was treated with 1 ml of 5N NaOH and heated on the thermostat for 80°C for 1 h and then cooled to room temperature and then neutralized with HCl and made up to volume with mobile phase and filtered through 0.45 µ membrane filter. 20 µL of this solution was injected into the system, and the peak area was noted from the corresponding chromatogram.
For peroxide degradation, 2.5 ml of drug solution was taken into a 25 ml volumetric flask and diluted with 10 ml of mobile phase. This solution was sonicated for 30 min and then treated with 5 ml of 30% hydrogen peroxide. Later, it was heated on a thermostat at 80°C for 30 min and cooled to room temperature. The resultant solution mixture was filtered through 0.45 µ membrane filter. 20 µL of this solution was injected into the system, and the peak area was noted from the corresponding chromatogram.
RESULTS AND DISCUSSION
A simple and robust reverse-phase liquid chromatographic method has been developed, and stress studies were performed in palbociclib API in an Inertsil ODS 3V column with ammonium acetate and ACN mixture as the mobile phase. The presently proposed method was compared with the previously published methods in the literature in Table 1 .
Method Development and Optimization
RP-HPLC system was initially optimized using Inertsil ODS 3V column. A mixture of with ammonium acetate and ACN (38: 62, v/v) as the mobile phase (Flow rate 1.0 mL/min) was found to be more appropriate to satisfy the system suitability parameters. The optimized chromatographic conditions were summarized in Table 2 . Palbociclib was eluted as a sharp peak at 3.338 ± 0.05 min [ Figure 2 ].
Method Validation
The proposed method was validated by linearity, precision, accuracy, and robustness as per the ICH guidelines. The Figure 3 ]. The LOD and LOQ are found to be 1.6378 µg/mL and 4.951 µg/mL, respectively.
Intraday and interday precision was studied using three different concentrations of palbociclib on the same day and 3 consecutive days, respectively, and the percentage relative standard deviation (RSD) was found to be 0.21-0.42 and 0.39-0.98, respectively (<2.0%), demonstrating that the method is precise [ Tables 4  and 5 ]. The accuracy of the method was proved by the standard addition method, and the recovery values were determined [ Table 6 ]. The percentage RSD was found to be 0.32-0.83 (<2.0%) with a recovery of 98.51-98.72%. The percentage RSD was found to be 0.41-1.02 (<2.0%) in robustness study. The system suitability and solution stability were evaluated, and the percentage RSD was <2%.
Stress Degradation Studies
Palbociclib was exposed to various stress conditions such as acidic, oxidative, and alkaline hydrolysis. In acidic hydrolysis, ). In all the degradation studies, it was found that the palbociclib peak was well separated among the degradants indicating that the method is selective and specific. The system suitability parameters were well in the acceptance criteria [ Table 7 ]. The theoretical plates are above 25000 (Acceptance criteria > 2000) and tailing factor is <1.5. Figure 4 shows the typical chromatograms obtained in absence and presence of palbociclib during stress degradation study.
Assay of Palbociclib
Palbociclib is still under development, and therefore, Palbociclib capsules were prepared in our laboratory with the available excipients and then extracted with mobile phase. This solution was filtered and diluted as per the requirement with mobile phase. The percentage recovery of palbociclib was found to be 98.93-99.21%. No interference of excipients was observed.
CONCLUSIONS
The validated stability indicting method developed for the determination of Palpociclib is specific and selective and more economical. Palpociclib is found to be more sensitive towards oxidation than alkaline environment. This method can be excellently applied for the determination of Palpociclib in pharmaceutical formulations.
